BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17178855)

  • 1. HMGA1 is a determinant of cellular invasiveness and in vivo metastatic potential in pancreatic adenocarcinoma.
    Liau SS; Jazag A; Whang EE
    Cancer Res; 2006 Dec; 66(24):11613-22. PubMed ID: 17178855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High mobility group AT-hook 1 (HMGA1) is an independent prognostic factor and novel therapeutic target in pancreatic adenocarcinoma.
    Liau SS; Rocha F; Matros E; Redston M; Whang E
    Cancer; 2008 Jul; 113(2):302-14. PubMed ID: 18473350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of HMGA1 promotes anoikis resistance and constitutive Akt activation in pancreatic adenocarcinoma cells.
    Liau SS; Jazag A; Ito K; Whang EE
    Br J Cancer; 2007 Mar; 96(6):993-1000. PubMed ID: 17342093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMGA1 is a molecular determinant of chemoresistance to gemcitabine in pancreatic adenocarcinoma.
    Liau SS; Whang E
    Clin Cancer Res; 2008 Mar; 14(5):1470-7. PubMed ID: 18316571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HMGA1-COX-2 axis: a key molecular pathway and potential target in pancreatic adenocarcinoma.
    Hillion J; Smail SS; Di Cello F; Belton A; Shah SN; Huso T; Schuldenfrei A; Nelson DM; Cope L; Campbell N; Karikari C; Aderinto A; Maitra A; Huso DL; Resar LM
    Pancreatology; 2012; 12(4):372-9. PubMed ID: 22898640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lentivirus-mediated RNA interference of HMGA1 promotes chemosensitivity to gemcitabine in pancreatic adenocarcinoma.
    Liau SS; Ashley SW; Whang EE
    J Gastrointest Surg; 2006 Nov; 10(9):1254-62; discussion 1263. PubMed ID: 17114012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of MMP-2 by HMGA1 promotes transformation in undifferentiated, large-cell lung cancer.
    Hillion J; Wood LJ; Mukherjee M; Bhattacharya R; Di Cello F; Kowalski J; Elbahloul O; Segal J; Poirier J; Rudin CM; Dhara S; Belton A; Joseph B; Zucker S; Resar LM
    Mol Cancer Res; 2009 Nov; 7(11):1803-12. PubMed ID: 19903768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CEACAM6 is a determinant of pancreatic adenocarcinoma cellular invasiveness.
    Duxbury MS; Ito H; Benoit E; Ashley SW; Whang EE
    Br J Cancer; 2004 Oct; 91(7):1384-90. PubMed ID: 15316565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMGA1 controls transcription of insulin receptor to regulate cyclin D1 translation in pancreatic cancer cells.
    Kolb S; Fritsch R; Saur D; Reichert M; Schmid RM; Schneider G
    Cancer Res; 2007 May; 67(10):4679-86. PubMed ID: 17510394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of CEACAM6 promotes insulin-like growth factor I-induced pancreatic adenocarcinoma cellular invasiveness.
    Duxbury MS; Ito H; Benoit E; Zinner MJ; Ashley SW; Whang EE
    Oncogene; 2004 Jul; 23(34):5834-42. PubMed ID: 15208677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E2 enhances pancreatic cancer invasiveness through an Ets-1-dependent induction of matrix metalloproteinase-2.
    Ito H; Duxbury M; Benoit E; Clancy TE; Zinner MJ; Ashley SW; Whang EE
    Cancer Res; 2004 Oct; 64(20):7439-46. PubMed ID: 15492268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMGA1 exacerbates tumor progression by activating miR-222 through PI3K/Akt/MMP-9 signaling pathway in uveal melanoma.
    Cheng Y; Cheng T; Zhao Y; Qu Y
    Cell Signal; 2019 Nov; 63():109386. PubMed ID: 31394192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ionizing radiation enhances matrix metalloproteinase-2 secretion and invasion of glioma cells through Src/epidermal growth factor receptor-mediated p38/Akt and phosphatidylinositol 3-kinase/Akt signaling pathways.
    Park CM; Park MJ; Kwak HJ; Lee HC; Kim MS; Lee SH; Park IC; Rhee CH; Hong SI
    Cancer Res; 2006 Sep; 66(17):8511-9. PubMed ID: 16951163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-137, an HMGA1 target, suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2.
    Liang L; Li X; Zhang X; Lv Z; He G; Zhao W; Ren X; Li Y; Bian X; Liao W; Liu W; Yang G; Ding Y
    Gastroenterology; 2013 Mar; 144(3):624-635.e4. PubMed ID: 23201162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RRM2 induces NF-kappaB-dependent MMP-9 activation and enhances cellular invasiveness.
    Duxbury MS; Whang EE
    Biochem Biophys Res Commun; 2007 Mar; 354(1):190-6. PubMed ID: 17222798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The High Mobility Group A1 (HMGA1) gene is highly overexpressed in human uterine serous carcinomas and carcinosarcomas and drives Matrix Metalloproteinase-2 (MMP-2) in a subset of tumors.
    Hillion J; Roy S; Heydarian M; Cope L; Xian L; Koo M; Luo LZ; Kellyn K; Ronnett BM; Huso T; Armstrong D; Reddy K; Huso DL; Resar LMS
    Gynecol Oncol; 2016 Jun; 141(3):580-587. PubMed ID: 27001612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. eEF1A2 promotes cell migration, invasion and metastasis in pancreatic cancer by upregulating MMP-9 expression through Akt activation.
    Xu C; Hu DM; Zhu Q
    Clin Exp Metastasis; 2013 Oct; 30(7):933-44. PubMed ID: 23739844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing of high mobility group A1 enhances gemcitabine chemosensitivity of lung adenocarcinoma cells.
    Cao YD; Huang PL; Sun XC; Ma J; Jin ZL; Cheng HY; Xu RZ; Li F; Qin SK; Deng YX; Ge XL
    Chin Med J (Engl); 2011 Apr; 124(7):1061-8. PubMed ID: 21542969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-24 modulates the high mobility group (HMG) A1/miR222 /AKT signaling in lung cancer cells.
    Panneerselvam J; Srivastava A; Muralidharan R; Wang Q; Zheng W; Zhao L; Chen A; Zhao YD; Munshi A; Ramesh R
    Oncotarget; 2016 Oct; 7(43):70247-70263. PubMed ID: 27602961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gli1 contributes to the invasiveness of pancreatic cancer through matrix metalloproteinase-9 activation.
    Nagai S; Nakamura M; Yanai K; Wada J; Akiyoshi T; Nakashima H; Ohuchida K; Sato N; Tanaka M; Katano M
    Cancer Sci; 2008 Jul; 99(7):1377-84. PubMed ID: 18410405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.